Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human study
Celine B.E. Busch, Suzanne Meiring, Annieke C G van Baar, F. Holleman, Max Nieuwdorp, Jacques J G H M Bergman
Topics & Concepts
MedicineAgonistType 2 diabetesGlucagon-like peptide 1 receptorInsulinGlucagon-like peptide-1Internal medicineEndocrinologyDuodenumDiabetes mellitusReceptorMicrobial Inactivation MethodsTissue Engineering and Regenerative MedicinePancreatic function and diabetes